SunTrust Robinson Humphrey Upgrades Sarepta Therapeutics To Buy By: Benzinga via Benzinga May 20, 2015 at 08:58 AM EDT SunTrust Robinson Humphrey upgraded Sarepta Therapeutics Inc (NASDAQ: SRPT) from Neutral to Buy. The price target for Sarepta ... Read More >> Related Stocks: Sarepta Therapeutics